Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer. - PubMed - NCBI

Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer. - PubMed - NCBI

Ann Oncol. 2017 Oct 1;28(10):2620-2621. doi: 10.1093/annonc/mdx292.

Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer.

Sciallero S1, Battistuzzi L2,3, Varesco L4.

Author information

Comment in

• Reply to the letter to the editor 'Including lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer' by Sciallero et al. [Ann Oncol. 2017]

Comment on

• Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. [Ann Oncol. 2017]

PMID:

 

28945832

 

DOI:

 

10.1093/annonc/mdx292

[Indexed for MEDLINE]